Considering that Chr.11-LOH occurs in about 40% of parathyroid adenomas and MEN1 expression is variably conserved in parathyroid tumors, we chose to silence MEN1 gene expression in order to evaluate the effect of its complete loss (Figure 2B). The gene discussed is MEN1; the disease is parathyroid gland adenoma.